The Polish company, located in south-west Poland was established in 2018 and is one of the innovative regional companies in the biotechnological trade.
The team of SME technologists has developed a proprietary technology for obtaining a universal transdermal therapeutic system. Thanks to the unique properties of the system, it is possible to increase the bioavailability of active substances by several times, allowing active substances to penetrate through skin barriers up to several centimetres, reaching soft tissues and bones. The unique transdermal system can be easily modified to achieve a targeted action in pathologically changed tissues.
The company products in the pipeline:
- Innovation technology: a transport system created on the basis of non-aggregating molecules to increase the surface area of the release of solid drug form.
- Drug candidate: local anesthetic ointment
- Drug candidate: tissue regeneration ointment
- Drug candidate: propriate drug for breast cancer treating
All products & technologies are protected by patent applications.
In connection with increasing company competition on the market, the SME plans to introduce new products to their customers. Therefore, the company is currently looking for industry partners to carry out the POC Phase project to connect the original system carrier with the partner's API (Active Pharmaceutical Ingredients) in terms of license agreement.